I. Shchepotin

3.2k total citations · 1 hit paper
40 papers, 2.4k citations indexed

About

I. Shchepotin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, I. Shchepotin has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in I. Shchepotin's work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (7 papers) and Metastasis and carcinoma case studies (5 papers). I. Shchepotin is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (7 papers) and Metastasis and carcinoma case studies (5 papers). I. Shchepotin collaborates with scholars based in United States, Ukraine and Malaysia. I. Shchepotin's co-authors include Joan Maurel, David Cunningham, Eric Van Cutsem, Marek P. Nowacki, Stefano Cascinu, Gunnar Folprecht, Angela Zubel, Fortunato Ciardiello, Ilhan Celik and Philippe Rougier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

I. Shchepotin

34 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

2011 1.4k citations Eric Van Cutsem, Claus-Henning Köhne et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Shchepotin United States	18	1.7k	860	670	462	438	40	2.4k
Laura W. Goff United States	21	1.0k 0.6×	432 0.5×	340 0.5×	347 0.8×	742 1.7×	77	2.0k
Alessio Amatu Italy	24	1.5k 0.9×	826 1.0×	573 0.9×	200 0.4×	598 1.4×	80	2.4k
Luca Faloppi Italy	25	807 0.5×	499 0.6×	262 0.4×	457 1.0×	580 1.3×	92	1.8k
Weijian Guo China	15	589 0.4×	572 0.7×	172 0.3×	153 0.3×	304 0.7×	72	1.4k
Raphaël Maréchal Belgium	22	1.5k 0.9×	403 0.5×	180 0.3×	148 0.3×	497 1.1×	63	2.3k
M Imamura Japan	27	1.2k 0.7×	552 0.6×	240 0.4×	310 0.7×	1.5k 3.4×	79	2.9k
Michela Del Prete Italy	25	857 0.5×	369 0.4×	157 0.2×	203 0.4×	362 0.8×	75	1.9k
Leizhen Zheng China	19	1.2k 0.7×	1.2k 1.4×	276 0.4×	73 0.2×	717 1.6×	40	2.3k
Shunchang Jiao China	30	1.9k 1.1×	977 1.1×	229 0.3×	122 0.3×	1.1k 2.6×	144	3.4k
Mary M. Sugrue United States	18	1.3k 0.8×	474 0.6×	225 0.3×	296 0.6×	929 2.1×	48	2.2k

Countries citing papers authored by I. Shchepotin

Since Specialization

Citations

This map shows the geographic impact of I. Shchepotin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Shchepotin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Shchepotin more than expected).

Fields of papers citing papers by I. Shchepotin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Shchepotin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Shchepotin. The network helps show where I. Shchepotin may publish in the future.

Co-authorship network of co-authors of I. Shchepotin

This figure shows the co-authorship network connecting the top 25 collaborators of I. Shchepotin. A scholar is included among the top collaborators of I. Shchepotin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Shchepotin. I. Shchepotin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chernyavsky, Alex I., I. Shchepotin, & Sergei A. Grando. (2015). Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors. International Immunopharmacology. 29(1). 36–44. 40 indexed citations

Chernyavsky, Alex I., et al.. (2015). Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer. 15(1). 152–152. 44 indexed citations

Shchepotin, I., et al.. (2014). The clinical significance of breast cancer stem cells (review of literature). SHILAP Revista de lepidopterología. 2 indexed citations

Vé, Orel, M. Tselepi, T. Mitrelias, et al.. (2014). Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin. Nanomedicine Nanotechnology Biology and Medicine. 11(1). 47–55. 69 indexed citations

Chernyavsky, Alex I., Valentin Galitovskiy, I. Shchepotin, & Sergei A. Grando. (2014). Anti-Inflammatory Effects of the Nicotinergic Peptides SLURP-1 and SLURP-2 on Human Intestinal Epithelial Cells and Immunocytes. BioMed Research International. 2014. 1–7. 28 indexed citations

Shchepotin, I., et al.. (2014). 363. Surgical treatment of rectal cancer with synchronous liver metastasis. European Journal of Surgical Oncology. 40(11). S140–S141.

Vé, Orel, T. Mitrelias, M. Tselepi, et al.. (2014). Imaging of Guerin Carcinoma During Magnetic Nanotherapy. 2(1). 58–68. 1 indexed citations

Shchepotin, I., et al.. (2013). D2 Gastrectomy with Versus Without Bursectomy for Gastric Cancer: Result of Single Center Randomized Trial. Annals of Oncology. 24. iv65–iv65. 2 indexed citations

Cutsem, Eric Van, Claus-Henning Köhne, István Láng, et al.. (2011). Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. Journal of Clinical Oncology. 29(15). 2011–2019. 1441 indexed citations breakdown →

10.

Cutsem, Eric Van, Marek P. Nowacki, István Láng, et al.. (2007). Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial. Journal of Clinical Oncology. 25(18_suppl). 4000–4000. 233 indexed citations

11.

Evans, Stephen R.T., et al.. (2000). 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model.. International Journal of Oncology. 16(6). 1249–54. 41 indexed citations

12.

Evans, Stephen R.T., et al.. (1999). Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis.. International Journal of Oncology. 14(5). 979–85. 23 indexed citations

13.

Shchepotin, I., et al.. (1999). Palliative superselective intra-arterial chemotherapy for advanced nonresectable gastric cancer. Journal of Gastrointestinal Surgery. 3(4). 426–431. 8 indexed citations

14.

Shchepotin, I., et al.. (1998). Extended surgical resection in T4 gastric cancer. The American Journal of Surgery. 175(2). 123–126. 64 indexed citations

15.

Evans, Scott, et al.. (1998). Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.. PubMed. 4(11). 2869–76. 27 indexed citations

16.

Shchepotin, I., В А Солдатенков, Jarda T. Wroblewski, et al.. (1997). Apoptosis induced by hyperthermia and verapamilin vitroin a human colon cancer cell line. International Journal of Hyperthermia. 13(5). 547–557. 12 indexed citations

17.

Shchepotin, I., et al.. (1996). Primary non-Hodgkin's lymphoma of the stomach: Three radical modalities of treatment in 75 patients. Annals of Surgical Oncology. 3(3). 277–284. 17 indexed citations

18.

Shchepotin, I., et al.. (1996). Postoperative complications requiring relaparotomies after 700 gastrectomies performed for gastric cancer. The American Journal of Surgery. 171(2). 270–273. 38 indexed citations

19.

Shchepotin, I., et al.. (1994). In vitro Effect of 5-Fluorouracil, Verapamil and Hyperthermia on the Human Pancreatic Adenocarcinoma Cell Line ASPC-1. Chemotherapy. 40(5). 348–356. 7 indexed citations

20.

Shchepotin, I., Stephen R.T. Evans, Sergej Osinsky, et al.. (1994). Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surgical Oncology. 3(1). 37–44. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact